2.37
Schlusskurs vom Vortag:
$2.47
Offen:
$2.45
24-Stunden-Volumen:
2.38M
Relative Volume:
1.47
Marktkapitalisierung:
$260.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-134.24M
KGV:
-1.339
EPS:
-1.77
Netto-Cashflow:
$-121.34M
1W Leistung:
-5.20%
1M Leistung:
-0.42%
6M Leistung:
-42.89%
1J Leistung:
-59.31%
Annexon Inc Stock (ANNX) Company Profile
Firmenname
Annexon Inc
Sektor
Branche
Telefon
(650)-822-5500
Adresse
1400 SIERRA POINT PARKWAY, BRISBANE
Vergleichen Sie ANNX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ANNX
Annexon Inc
|
2.37 | 274.29M | 0 | -134.24M | -121.34M | -1.77 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-03-01 | Hochstufung | JP Morgan | Neutral → Overweight |
2023-12-21 | Hochstufung | BofA Securities | Neutral → Buy |
2023-10-30 | Eingeleitet | Wells Fargo | Overweight |
2023-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
2023-05-25 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-09-16 | Eingeleitet | Jefferies | Buy |
2022-09-09 | Eingeleitet | BTIG Research | Buy |
2021-11-30 | Eingeleitet | H.C. Wainwright | Buy |
2021-09-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
2021-01-26 | Eingeleitet | Needham | Buy |
2020-08-18 | Eingeleitet | BofA Securities | Buy |
2020-08-18 | Eingeleitet | Cowen | Outperform |
2020-08-18 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Annexon Inc Aktie (ANNX) Neueste Nachrichten
Annexon Inc. Stock Analysis and ForecastFree Stock Selection - Autocar Professional
What analysts say about Annexon Inc. stockFast-track wealth growth - jammulinksnews.com
What drives Annexon Inc. stock priceRapidly expanding wealth - jammulinksnews.com
Is Annexon Inc. a good long term investmentHigh-performance investment picks - Autocar Professional
Why Annexon Inc. stock attracts strong analyst attentionCapital Doubling Tips - Newser
Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans? - 富途牛牛
Is Annexon Inc. stock a growth or value playHigh Reward Risk Balanced Trading - Newser
Annexon Inc (ANNX) Stock: A Comprehensive 52-Week Review - investchronicle.com
Annexon EVP Yednock sells $2.9k in shares By Investing.com - Investing.com South Africa
Annexon EVP Yednock sells $2.9k in shares - Investing.com Australia
What makes Annexon Inc. stock price move sharplyTop Performing Stocks - Newser
How Annexon Inc. stock performs during market volatilityWeekly Big Movers - Newser
Annexon: Lead GBS Therapy Stokes Near Term Potential (NASDAQ:ANNX) - Seeking Alpha
Annexon Target of Unusually Large Options Trading (NASDAQ:ANNX) - Defense World
Annexon (NASDAQ:ANNX) Stock Price Down 0.7% – Should You Sell? - Defense World
Annexon says enrollment of Phase 3 Archer II Trial expected to be completed in Q3 2025 - MarketScreener
Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrop - GuruFocus
Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA) - GlobeNewswire
Bank of America Corp DE Sells 137,220 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Annexon, Inc. (NASDAQ:ANNX) Shares Sold by Park Avenue Securities LLC - Defense World
Market Highlights: Annexon Inc (ANNX) Ends on a Low Note at 2.49 - DWinneX
49,062 Shares in Annexon, Inc. (NASDAQ:ANNX) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Annexon, Inc. (NASDAQ:ANNX) Shares Bought by California State Teachers Retirement System - Defense World
Cantor Fitzgerald Estimates Annexon FY2026 Earnings - Defense World
Annexon Biosciences Holds Annual Stockholders Meeting - TipRanks
Two Sigma Advisers LP Reduces Stock Holdings in Annexon, Inc. (NASDAQ:ANNX) - Defense World
Squarepoint Ops LLC Sells 49,438 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Millennium Management LLC Grows Stake in Annexon, Inc. (NASDAQ:ANNX) - Defense World
Finanzdaten der Annexon Inc-Aktie (ANNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):